Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -253,350 | -119,055 | -614,453 | -378,482 | -220,096 |
| Depreciation Amortization | 10,022 | 4,880 | 18,921 | 13,417 | 9,371 |
| Accounts receivable | -11,684 | -10,313 | -12,149 | -6,118 | -6,064 |
| Accounts payable and accrued liabilities | 10,158 | 15,281 | 48,406 | 22,690 | 8,471 |
| Other Working Capital | -62,062 | -25,761 | -13,141 | -5,343 | -33,644 |
| Other Operating Activity | -20,392 | -22,869 | 50,148 | -2,728 | -29,603 |
| Operating Cash Flow | $-327,308 | $-157,837 | $-522,269 | $-356,563 | $-271,564 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 282,558 | 227,272 | 295,564 | 226,157 | 144,879 |
| PPE Investments | -1,667 | -1,165 | -5,220 | -1,180 | 2,119 |
| Purchase Of Investment | N/A | N/A | -225,304 | -161,997 | -95,459 |
| Investing Cash Flow | $280,890 | $226,107 | $65,041 | $62,979 | $51,539 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 530,257 | 506,905 | 535,592 |
| Common Stock Issued | 2,262 | 2,003 | 5,429 | 2,038 | 730 |
| Common Stock Repurchased | N/A | N/A | -110,949 | -106,061 | -112,065 |
| Other Financing Activity | -5,545 | -2,757 | -6,697 | -4,610 | -3,366 |
| Financing Cash Flow | $-3,283 | $-754 | $418,040 | $398,271 | $420,891 |
| Exchange Rate Effect | -5,414 | -6,855 | 37,607 | 58,543 | 39,770 |
| Beginning Cash Position | 484,974 | 477,413 | 470,187 | 449,480 | 474,917 |
| End Cash Position | 429,860 | 538,075 | 468,607 | 612,710 | 715,554 |
| Net Cash Flow | $-55,114 | $60,662 | $-1,580 | $163,230 | $240,637 |
| Free Cash Flow | |||||
| Operating Cash Flow | -327,308 | -157,837 | -522,269 | -356,563 | -271,564 |
| Capital Expenditure | -1,667 | -1,165 | -15,266 | -10,784 | -8,028 |
| Free Cash Flow | -328,975 | -159,002 | -537,534 | -367,347 | -279,592 |